|
End-of-day quote
Bulgaria S.E.
08/10/2026
|
5-day change | 1st Jan Change | ||
| 2.620 EUR | -0.38% |
|
+1.55% | +83.92% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.63B 1.58B 1.41B 1.32B 1.2B 2.25B 153B 2.27B 15.8B 6.18B 77.74B 5.93B 5.8B 250B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.17B 1.9B 1.7B 1.59B 1.44B 2.71B 184B 2.74B 19.05B 7.45B 93.74B 7.15B 7B 301B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | -0.38% | ||
| 1 week | +1.55% | ||
| Current month | +1.16% | ||
| 1 month | +6.94% | ||
| 3 months | +35.75% | ||
| 6 months | +49.71% | ||
| Current year | +83.92% |
| 1 week | 2.49 |  | 2.64 |
| 1 month | 2.45 | | 2.64 |
| Current year | 1.41 | | 2.64 |
| 1 year | 1.34 | | 2.64 |
| 3 years | 0.94 | | 2.64 |
| 5 years | 0.64 | | 2.64 |
| 10 years | 0.41 | | 2.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 30/09/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 31/12/2001 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 18/05/2010 |
| Director/Board Member | 63 | 18/05/2010 | |
| Director/Board Member | 61 | 11/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | +1.55% | +92.64% | +110.37% | 1.58B | |
| +1.36% | +3.46% | -43.78% | -5.93% | 14.36B | |
| -0.85% | +11.16% | +11.71% | -23.97% | 7.37B | |
| +0.35% | +1.60% | -15.45% | -8.25% | 6.07B | |
| -0.47% | +2.98% | -13.51% | -2.32% | 5.98B | |
| +1.25% | +1.07% | -55.41% | -39.72% | 5.81B | |
| +0.94% | +0.94% | -4.54% | -19.49% | 4.22B | |
| +1.07% | +3.71% | -23.40% | -19.14% | 3.17B | |
| -0.66% | -0.22% | -24.19% | -35.99% | 3.17B | |
| +0.88% | +0.88% | +11.34% | -27.00% | 3.09B | |
| Average | +0.36% | +2.86% | -6.46% | -7.14% | 5.48B | |
| Weighted average by Cap. | +0.50% | +2.53% | -18.73% | -13.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.07B 972M 1.83B 124B 1.85B 12.85B 5.03B 63.24B 4.82B 4.72B 203B | 2.63B 1.58B 1.41B 1.32B 1.2B 2.25B 153B 2.27B 15.81B 6.19B 77.82B 5.94B 5.81B 250B |
| Net income | 77.85M 46.75M 41.75M 38.95M 35.38M 66.58M 4.53B 67.23M 468M 183M 2.3B 176M 172M 7.4B | 134M 80.19M 71.61M 66.81M 60.69M 114M 7.77B 115M 802M 314M 3.95B 301M 295M 12.69B |
| Net Debt | 444M 267M 238M 222M 202M 380M 25.84B 384M 2.67B 1.04B 13.13B 1B 980M 42.22B | 541M 325M 290M 271M 246M 463M 31.48B 467M 3.25B 1.27B 16B 1.22B 1.19B 51.45B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | €2.620 | -0.38% | 36,162 |
| 07/10/26 | €2.630 | +5.20% | 57,438 |
| 06/10/26 | €2.500 | 0.00% | 18,280 |
| 05/10/26 | €2.500 | -3.10% | 8,959 |
| 02/10/26 | €2.580 | 0.00% | 9,093 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
